| 前收市價 | 1.0500 |
| 開市 | 1.0500 |
| 買盤 | 2.9500 |
| 賣出價 | 4.3000 |
| 拍板 | 7.50 |
| 到期日 | 2024-10-18 |
| 今日波幅 | 1.0500 - 1.0500 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 42 |
InvestorPlace3 Biotech Stocks That Could Be Millionaire-Makers: May Edition
As we delve deeper into 2024, biotech stocks are commanding the attention of growth-focused investors. Despite facing volatility and regulatory challenges in recent years, biotech is poised for a resurgence. Breakthroughs in personalized medicine and gene editing technologies are driving biotech forward. The global biotechnology market was valued at $1.0 trillion in 2022 and is projected to reach $3.6 trillion by 2032. Increasing demand for personalized medicine and advancements in genetic engin
Insider MonkeyMacroGenics, Inc. (NASDAQ:MGNX) Q1 2024 Earnings Call Transcript
MacroGenics, Inc. (NASDAQ:MGNX) Q1 2024 Earnings Call Transcript May 10, 2024 MacroGenics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon. We will begin the MacroGenics 2024 First Quarter Corporate Progress and Financial Results Conference Call in just […]
Motley FoolMacroGenics (MGNX) Q1 2024 Earnings Call Transcript
MGNX earnings call for the period ending March 31, 2024.
